PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page

FDA Approves a New Generic Valsartan to Mitigate Shortages

by PEPID Newsroom | Mar 14, 2019 | Alerts

As of March 12, 2019 the U.S. FDA approved a new generic of Diovan (valsartan) for high blood pressure and heart failure to relieve the shortage from multiple recalls of generic valsartan products from several manufacturers. The approval of the new generic of Diovan...

Recent Posts

  • What Is a DNP? Everything You Need to Know About the Doctor of Nursing Practice
  • Halloween Health & Safety: Tips for Families and Clinicians
  • Exploring a Career in Nursing: What You Need to Know
  • Back-to-School Wellness — A Resource for Families and Providers
  • The Summer Injury Spike: Common ER Visits and How to Prevent Them

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved